Forbion Appoints Dr. Carlo Incerti as Operating Partner

03:00 EST 29 Nov 2018 | Businesswire
This article has expired, however you can still download the PDF.
Forbion, a leading European life science venture capital firm, today announces that Carlo Incerti, M.D., will be joining Forbion as Operating Partner, effective 1 January 2019. A medical doctor by training, Dr. Carlo In...

Other Sources for this Article

Forbion contact:
Sander Slootweg
Managing Partner
P: +31 (0) 35 699 30 00

Media contact:
Instinctif Partners
Melanie Toyne-Sewell/Ashley Tapp
P: +44 (0) 20 7457 2020


More From BioPortfolio on "Forbion Appoints Dr. Carlo Incerti as Operating Partner"

Quick Search

Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...